Hoth Therapeutics Announces Participation in Sequire Investor Summit Happening January 21-23, 2025 Hoth Therapeutics will be represented by CEO Robb Knie at the upcoming Sequire Investor Summit from January 21-23, 2025, in New York.

Hoth Therapeutics Announces Participation in Sequire Investor Summit Happening January 21-23, 2025 #United_States #New_York #Hoth_Therapeutics #Robb_Knie #Sequire_Investor_Summit